English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduResearchers note that health care providers are now able to add to their armamentarium against COVID-19 their prescription of this new antiviral drug for high-risk, newly-infected patients as soon as possible following diagnosis or within five days of the onset of symptoms.
Tag: Emergency Use Authorization
Rutgers University’s Resilient, Innovative Year Confronting COVID-19
The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.
AACI Applauds Approval of COVID-19 Vaccine, Supports Widespread Vaccination Efforts
The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.
Story Tips from Johns Hopkins Experts on Covid-19
Vaccines that prevent infection by SARS-CoV-2, the virus that causes COVID-19, are being rolled out around the world. Below are five things about vaccine science of which you may be unaware. Additionally, here is a video about how vaccines are determined safe.
Penn Medicine mRNA Vaccine Technology Pioneer and Health Policy Experts Join Together to Discuss COVID Vaccine Emergency Use Authorization Plans
**All experts also available for interviews prior to event and EUA Advisory Committee Meetings**
**B-roll and lab photos of Drs. Weissman and Wherry shot this month, headshots of the others, and photos from Penn’s Moderna vaccine trial participants getting vaccinated, are available for use**
Principal Investigator for COVID-19 drug with FDA Emergency Use Authorization available to speak on limited government supply of drug and pending clinical trials
COVID-19 and Monoclonal Antibodies – Emergency Use Authorization for Bamlanivimab The FDA’s Emergency Use Authorization to treat high risk COVID-19 patients with the monoclonal antibody bamlanivimab will offer limited availability in Texas, where only 6,000 government doses are expected next…
Scientists pioneer faster, cheaper COVID-19 testing technology
The U.S. Food and Drug Administration has granted emergency use authorization for UCLA Health to launch a new method of COVID-19 detection using sequencing technology called SwabSeq. Capable of testing thousands of samples at once, the method returns accurate, individual results in 12 to 24 hours.
Mount Sinai seeks EUA from Food and Drug Administration for potential quantitative serologic test for COVID-19
If authorized for quantitative use, the assay could be used to provide a numeric result for the concentration of neutralizing anti-COVID-19 antibodies in plasma.